News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2016 On August 4, 2016

BOULDER, Colo., July 27, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the fourth quarter and full year of fiscal 2016 and hold a conference call to discuss those results on Thursday, August 4, 2016.  Ron Squarer, Chief Executive Officer, will lead the call.

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.)

 

Date:               

Thursday, August 4, 2016

Time:              

9:00 a.m. Eastern Time

Toll-Free:        

(844) 464-3927

Toll:                

(765) 507-2598

Pass Code:      

55520532

Webcast, including Replay and Conference Call Slides:
http://edge.media-server.com/m/p/9vx5kngz

 

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.

CONTACT:  

Tricia Haugeto    


Array BioPharma Inc.


(303) 386-1193


thaugeto@arraybiopharma.com

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-report-financial-results-for-the-fourth-quarter-and-full-year-of-fiscal-2016-on-august-4-2016-300305147.html

SOURCE Array BioPharma Inc.